Investigating the immune response in Takotsubo Cardiomyopathy
Novel role of ROCK2 in Immune Mechanisms of Takotsubo Cardiomyopathy
This study is looking at how the immune system affects Takotsubo Cardiomyopathy, a heart condition caused by extreme stress, to find new ways to help people who have had this condition.
Quick facts
| Grant type | Career grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Indiana University Indianapolis NIH-funded |
| Lab location | 1 site (Indianapolis, United States) |
| Project ID | NIH-11033681 on NIH RePORTER |
What this research studies
This research focuses on Takotsubo Cardiomyopathy (TCM), a serious heart condition triggered by extreme stress that leads to heart dysfunction. The study aims to understand the role of the immune system, particularly the involvement of macrophages and the enzyme ROCK2, in the development and progression of TCM. By examining how these immune mechanisms operate, the research seeks to identify potential treatment strategies for patients who have experienced TCM episodes. The approach includes both preclinical models and analysis of immune responses in human patients.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals who have experienced an episode of Takotsubo Cardiomyopathy and are at risk for further cardiovascular events.
Not a fit: Patients with chronic heart conditions unrelated to stress-induced cardiomyopathy may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new treatment options and improved care for patients recovering from Takotsubo Cardiomyopathy.
How similar studies have performed: Previous studies have shown promising results in understanding immune mechanisms in heart conditions, suggesting that this approach may yield valuable insights.
Where this research is happening
Indianapolis, United States
- Indiana University Indianapolis — Indianapolis, United States (Active)
Researchers
- Principal investigator: Fehrenbach, Daniel J — Indiana University Indianapolis
- Study coordinator: Fehrenbach, Daniel J
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.